Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04851548
NCT04851548UnknownNot Applicable

Evaluate the Effectiveness of Bioactive Hyaluronic Acid in the Treatment of Furcation Involvement

Riyadh Elm University0 sites18 target enrollmentStarted: September 23, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
18
Primary Endpoint
evaluate the regenerative effect of hyaluronic acid
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

the effect Hyaluronic Acid in the Treatment of Furcation Involvement

Detailed Description

The materials to be used in the study are the following:

  • Hyaluronic acid
  • Cone-beam computed tomography(CBCT) x-ray The patients with Grade II furcation will be divided into two groups. Both groups will have the same number of patients and the same procedure, such as the scaling root planning. However, the control group will use hyaluronic acid and membrane. The placebo group, on the other hand, will use hyaluronic acid without membrane and will use CBCT x-ray. The x-rays will be done at the beginning of the treatment. Then, two monitoring processes will be done. The first monitor will be done after three months. The data will be recorded. Then, after another three months, the patients will undergo an x-ray check again, and the data will be recorded. The goal is only to have the patients exposed to x-ray twice so they would not be compromised to the high dose of radiation. The evaluation to be done for the 3-month interval will only be clinical assessments.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Selected teeth: Permanent first and second molars in the mandible.
  • •Furcation dimension: Radiographic and clinical evidence of exhibiting defects due to Grade II furcation with at least 2 millimeters probing depth horizontally and at least 5 millimeters probing depth circumferential.
  • •Gender: both males and females.
  • •Age range: between 18 and 55 years.
  • •Health status: healthy patients non-systemic diseased except controlled diabetic.
  • •Compliance: Patients will be willing and able to comply with adequate oral hygiene protocols.

Exclusion Criteria

  • •Patients that received periodontal regenerative therapy within the past 12 months.
  • •Patients that are lactating.
  • •Pregnant patients.
  • •Patients with pulp infection.
  • •Patients with trauma resulting from occlusion.
  • •Patients with receding gum.
  • •Patients with tooth mobility greater than grade II.
  • •Patients that will not comply with the hygiene protocols in Phase I therapy.
  • •Patients with potential illnesses that can influence the periodontal therapy outcomes.
  • •Patients that are taking medications that can interfere with the healing outcomes of the periodontal wound.
  • •Patients allergic to any drugs.

Arms & Interventions

Group B (test)

Active Comparator

preoperative cone-beam computed tomography (CBCT )scans N= 9

  • open flap debridement.
  • use membrane and 8% hyaluronic acid gel (The first monitor will be done after three months. The data will be recorded. After another three months, the patients will undergo an x-ray check again, and the data will be registered. The goal is to have the patients exposed to x-ray twice not to be compromised to a high radiation dose. The evaluation to be done for the 3-month interval will only be clinical assessments|).

Intervention: hyaluronic acid (Procedure)

Group A (control)

Active Comparator

preoperative cone-beam computed tomography (CBCT) scans N=9

  • open flap debridement.
  • use membrane without hyaluronic acid. (The first monitor will be done after three months. The data will be recorded. After another three months, the patients will undergo an x-ray check again, and the data will be registered. The goal is to have the patients exposed to x-ray twice not to be compromised to a high radiation dose. The evaluation to be done for the 3-month interval will only be clinical assessments|)

Intervention: hyaluronic acid (Procedure)

Outcomes

Primary Outcomes

evaluate the regenerative effect of hyaluronic acid

Time Frame: 6 months

measurement of the bone gain after the treatment with hyaluronic acid in millimeters

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ghady Adnan Alqahtani

periodontic resident

Riyadh Elm University

Similar Trials

Completed
Not Applicable
Reconstruction of Interdental Papilla Using Hyaluronic AcidDefected Interdental Papilla
NCT02119741Damascus University30
Not yet recruiting
Phase 4
A study to evaluate the effectiveness of hyaluronic acid for managing the complications occurring after removal of impacted mandibular third molar.
CTRI/2023/05/053278Dr Alfisha Sheikh
Recruiting
Phase 4
Hyaluronic Acid for the Treatment of Damaged Nipples in Breastfeeding WomenCracked NippleBreastfeedingHealing Wound
NCT05591651Specijalisticka Pedijatrijska Ordinacija prim.mr.sc. Maja Stimac, Specijalist Pedijatrije Sspecijalnosti Neonatologije160
Completed
Phase 4
Effect of Topically-Applied Hyaluronic-Acid on Palatal Epithelial Wound ClosureWound Healing Complication
NCT02534415Marmara University36
Unknown
Phase 3
Role of Hyaluronic Acid in the Prevention of Post-operative Adhesions: a RCTPost Operative Adhesions
NCT02790177Services Institute of Medical Sciences, Pakistan150